ArticleFrontiers in oral health2026
Oral health status, treatment needs and oral health-related quality of life in patients with epidermolysis bullosa in Austria: a mixed-methods pilot study.
Article in Frontiers in oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epidermolysis bullosa (EB) is a rare genetic disease with skin and mucosal fragility. Severe cases present major physical and psychological compromise, contributing to comorbidities and reducing oral health-related quality of life (OHRQoL). Despite a multidisciplinary oral healthcare approach is recommended for EB patients, there is not a specific pathway available in Austria. This study aims to explore the oral health status, oral health treatment needs and OHRQoL in Austrian patients with EB. Materials and methods: A cross-sectional, mixed-methods and exploratory study with purposive sampling was conducted, combining clinical assessment with quantitative and qualitative data by using standardized questionnaires, including OHIP-14, COHIP, iscorEB-p, QOLEB, and open-ended questions. Extraoral and intraoral assessments were conducted, including PhOX as well as oral treatment needs. Quantitative data were analysed descriptively, while qualitative data were subjected to reflexive thematic analysis to explore recurring patterns and themes in participants' experiences. Results: A total of 14 participants with genetic diagnosis of EB were included: EB simplex (EBS, Conclusion: EB, particularly RDEB, has a significant impact on oral health and OHRQoL in Austrian participants. Compromised oral function strongly influences outcomes, but improvements do not always match treatment needs. This underscore the need for multidisciplinary management, including speech therapy, to improve their OHRQoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.